BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 310 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $95,808,523 | +8.8% | 633,780 | +4.9% | 0.02% | +8.7% |
Q2 2022 | $88,020,351 | +53.9% | 604,079 | +25.3% | 0.02% | +91.7% |
Q1 2022 | $57,176,233 | +3.0% | 482,215 | +19.7% | 0.01% | +9.1% |
Q4 2021 | $55,500,000 | +1.7% | 402,732 | +2.5% | 0.01% | -8.3% |
Q3 2021 | $54,579,000 | +35.7% | 392,909 | -5.2% | 0.01% | +33.3% |
Q2 2021 | $40,232,000 | +47.9% | 414,423 | +4.1% | 0.01% | +50.0% |
Q1 2021 | $27,199,000 | -37.5% | 397,939 | -21.6% | 0.01% | -40.0% |
Q4 2020 | $43,510,000 | +37.1% | 507,638 | +4.0% | 0.01% | +25.0% |
Q3 2020 | $31,742,000 | -15.4% | 488,268 | -4.9% | 0.01% | -27.3% |
Q2 2020 | $37,542,000 | +117.9% | 513,505 | +1.4% | 0.01% | +83.3% |
Q1 2020 | $17,232,000 | -34.1% | 506,370 | +5.4% | 0.01% | -14.3% |
Q4 2019 | $26,154,000 | +39.1% | 480,421 | +6.6% | 0.01% | +16.7% |
Q3 2019 | $18,807,000 | -4.7% | 450,803 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $19,741,000 | +226.4% | 450,803 | +283.6% | 0.01% | +200.0% |
Q1 2019 | $6,048,000 | +348.3% | 117,510 | +135.0% | 0.00% | – |
Q4 2017 | $1,349,000 | -27.8% | 50,000 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $1,869,000 | +49.5% | 50,000 | 0.0% | 0.00% | – |
Q2 2017 | $1,250,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |